Barcelona, Spain

Pilar Lauzurica Gómez

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pilar Lauzurica Gómez: Innovator in Immune Regulation

Introduction

Pilar Lauzurica Gómez is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of immune regulation, particularly through her innovative patent that addresses unwanted immune responses. Her work is crucial in developing therapeutic methods for various disorders.

Latest Patents

Pilar holds a patent titled "Immune regulation based on the depletion of CD69+ cells." This patent discloses methods for treating subjects with disorders characterized by unwanted immune responses. The methods include administering an effective amount of an early activation molecule agonist, antagonist, or depletor to the subject. Additionally, her patent includes human monoclonal antibodies specific to early activation molecules and outlines their methods of use. She has 1 patent to her name.

Career Highlights

Throughout her career, Pilar has worked with esteemed institutions such as Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas. Her research has significantly advanced the understanding of immune responses and potential treatments.

Collaborations

Pilar has collaborated with notable colleagues in her field, including Francisco Sanchez-Madrid and Carlos Martinez Alonso. Their joint efforts have contributed to the advancement of research in immune regulation.

Conclusion

Pilar Lauzurica Gómez is a trailblazer in the field of immune regulation, with her innovative patent paving the way for new therapeutic approaches. Her contributions to science and collaboration with esteemed colleagues highlight her dedication to advancing medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…